Predictive Value of Clinical Judgment of Tumour Progression in Phase II Trials

por Kotecki, Nuria, Penel, Nicolas, Adenis, Antoine, Ferte, Charles, Clisant, Stéphanie
Publicado em 2012

Frequency of Certain Established Risk Factors in Soft Tissue Sarcomas in Adults: A Prospective Descriptive Study of 658 Cases

por Penel, Nicolas, Grosjean, Jessica, Robin, Yves Marie, Vanseymortier, Luc, Clisant, Stéphanie, Adenis, Antoine
Publicado em 2008

Improvement of the initial management of sarcomas after the dissemination of evidence-based guidelines depends on the primary sarcoma location: a population-based study

por Ligier, Karine, Maynou, Carlos, Leroy, Xavier, Robin, Yves-Marie, Martin, Philippe, Clisant, Stéphanie, Richard, Florence, Penel, Nicolas
Publicado no BMC Cancer (2015)

Determinants of patient delay in doctor consultation in head and neck cancers (Protocol DEREDIA)

por Christophe, Véronique, Leroy, Tanguy, Seillier, Mélanie, Duthilleul, Camille, Julieron, Morbize, Clisant, Stéphanie, Foncel, Jérôme, Vallet, Fanny, Lefebvre, Jean-Louis
Publicado em 2014

Clinical complete responders to definite chemoradiation or radiation therapy for oesophageal cancer: predictors of outcome

por Adenis, Antoine, Tresch, Emmanuelle, Dewas, Sylvain, Romano, Olivier, Messager, Mathieu, Amela, Eric, Clisant, Stéphanie, Kramar, Andrew, Mariette, Christophe, Mirabel, Xavier
Publicado em 2013

Megestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard care

por Penel, N, Clisant, S, Dansin, E, Desauw, C, Dégardin, M, Mortier, L, Vanhuyse, M, Bonodeau, F, Fournier, C, Cazin, J-L, Adenis, A
Publicado em 2010

Impact of early palliative care on overall survival of patients with metastatic upper gastrointestinal cancers treated with first-line chemotherapy: a randomised phase III trial

por Hutt, Emilie, Da Silva, Arlette, Bogart, Emilie, Le Lay-Diomande, Sara, Pannier, Diane, Delaine-Clisant, Stéphanie, Le Deley, Marie-Cécile, Adenis, Antoine
Publicado no BMJ Open (2018)

Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial

por Brodowicz, Thomas, Liegl-Atzwager, Bernadette, Tresch, Emmanuelle, Taieb, Sophie, Kramar, Andrew, Gruenwald, Viktor, Vanseymortier, Marie, Clisant, Stéphanie, Blay, Jean-Yves, Le Cesne, Axel, Penel, Nicolas
Publicado no BMC Cancer (2015)

Circulating vascular endothelial growth factor (VEGF) as predictive factor of progression-free survival in patients with advanced chordoma receiving sorafenib: an analysis from a p...

por Lebellec, Loic, Bertucci, François, Tresch-Bruneel, Emmanuelle, Bompas, Emmanuelle, Toiron, Yves, Camoin, Luc, Mir, Olivier, Laurence, Valerie, Clisant, Stephanie, Decoupigny, Emilie, Blay, Jean-Yves, Goncalves, Anthony, Penel, Nicolas
Publicado no Oncotarget (2016)

Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial

por Pannier, Diane, Adenis, Antoine, Bogart, Emilie, Dansin, Eric, Clisant-Delaine, Stéphanie, Decoupigny, Emilie, Lesoin, Anne, Amela, Eric, Ducornet, Sandrine, Meurant, Jean-Pierre, Le Deley, Marie-Cécile, Penel, Nicolas
Publicado no BMC Cancer (2018)

The FREGAT biobank: a clinico-biological database dedicated to esophageal and gastric cancers

por Mariette, Christophe, Renaud, Florence, Piessen, Guillaume, Gele, Patrick, Copin, Marie-Christine, Leteurtre, Emmanuelle, Delaeter, Christine, Dib, Malek, Clisant, Stéphanie, Harter, Valentin, Bonnetain, Franck, Duhamel, Alain, Christophe, Véronique, Adenis, Antoine
Publicado no BMC Cancer (2018)

A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted olid tumours

por Adenis, A, Ray-Coquard, I, Italiano, A, Chauzit, E, Bui-Nguyen, B, Blay, J-Y, Tresch-Bruneel, E, Fournier, C, Clisant, S, Amela, E Y, Cassier, P A, Molimard, M, Penel, N
Publicado em 2013

Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter stu...

por Adenis, Antoine, de la Fouchardiere, Christelle, Paule, Bernard, Burtin, Pascal, Tougeron, David, Wallet, Jennifer, Dourthe, Louis-Marie, Etienne, Pierre-Luc, Mineur, Laurent, Clisant, Stéphanie, Phelip, Jean-Marc, Kramar, Andrew, Andre, Thierry
Publicado no BMC Cancer (2016)

Erratum to: Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a mul...

por Adenis, Antoine, de la Fouchardiere, Christelle, Paule, Bernard, Burtin, Pascal, Tougeron, David, Wallet, Jennifer, Dourthe, Louis-Marie, Etienne, Pierre-Luc, Mineur, Laurent, Clisant, Stéphanie, Phelip, Jean-Marc, Kramar, Andrew, Andre, Thierry
Publicado no BMC Cancer (2016)

Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouracil-oxaliplatin—folinic acid (FOLFOX) for resectable esophageal and junctional cancer: the PROTECT-1402, ra...

por Messager, Mathieu, Mirabel, Xavier, Tresch, Emmanuelle, Paumier, Amaury, Vendrely, Véronique, Dahan, Laetitia, Glehen, Olivier, Vasseur, Frederique, Lacornerie, Thomas, Piessen, Guillaume, El Hajbi, Farid, Robb, William B., Clisant, Stéphanie, Kramar, Andrew, Mariette, Christophe, Adenis, Antoine
Publicado no BMC Cancer (2016)

Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)(†)

por Bompas, E., Le Cesne, A., Tresch-Bruneel, E., Lebellec, L., Laurence, V., Collard, O., Saada-Bouzid, E., Isambert, N., Blay, J. Y., Amela, E. Y., Salas, S., Chevreau, C., Bertucci, F., Italiano, A., Clisant, S., Penel, N.
Publicado no Ann Oncol (2015)

REGOSARC: Regorafenib versus placebo in doxorubicin‐refractory soft‐tissue sarcoma—A quality‐adjusted time without symptoms of progression or toxicity analysis

por Berry, Vincent, Basson, Laurent, Bogart, Emilie, Mir, Olivier, Blay, Jean‐Yves, Italiano, Antoine, Bertucci, François, Chevreau, Christine, Clisant‐Delaine, Stéphanie, Liegl‐Antzager, Bernadette, Tresch‐Bruneel, Emmanuelle, Wallet, Jennifer, Taieb, Sophie, Decoupigny, Emilie, Le Cesne, Axel, Brodowicz, Thomas, Penel, Nicolas
Publicado no Cancer (2017)

Sorafenib for Patients with Advanced Angiosarcoma: A Phase II Trial from the French Sarcoma Group (GSF/GETO)

por Ray-Coquard, Isabelle, Italiano, Antoine, Bompas, Emmanuelle, Le Cesne, Axel, Robin, Yves-Marie, Chevreau, Christine, Bay, Jacques-Olivier, Bousquet, Guilhem, Piperno-Neumann, Sophie, Isambert, Nicolas, Lemaitre, Laurent, Fournier, Charles, Gauthier, Eric, Collard, Olivier, Cupissol, Didier, Clisant, Stéphanie, Blay, Jean-Yves, Penel, Nicolas
Publicado em 2012

The ongoing French metastatic breast cancer (MBC) cohort: the example-based methodology of the Epidemiological Strategy and Medical Economics (ESME)

por Pérol, David, Robain, Mathieu, Arveux, Patrick, Mathoulin-Pélissier, Simone, Chamorey, Emmanuel, Asselain, Bernard, Berchery, Delphine, Gourgou, Sophie, Breton, Mathias, Delaine-Clisant, Stéphanie, Mons, Muriel, Diéras, Véronique, Carton, Matthieu, Guizard, Anne-Valérie, Laborde, Lilian, Laurent, Carine, Loeb, Agnès, Mouret-Reynier, Marie-Ange, Parent, Damien, Perrocheau, Geneviève, Campion, Loïc, Velten, Michel, Cailliot, Christian, Ezzalfani, Monia, Simon, Gaëtane
Publicado no BMJ Open (2019)